CoChat

Resistance acquisition to MDM2 inhibitors

Open access
Cinatl, Jindrich, Speidel, Daniel, Hardcastle, Ian, Michaelis, Martin · 2014 · Biochemical Society Transactions

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Abstract

Various experimental strategies aim to (re)activate p53 signalling in cancer cells. The most advanced clinically are small-molecule inhibitors of the autoregulatory interaction between p53 and MDM2 (murine double minute 2). Different MDM2 inhibitors are currently under investigation in clinical trials. As for other targeted anti-cancer therapy approaches, relatively rapid resistance acquisition may limit the clinical efficacy of MDM2 inhibitors. In particular, MDM2 inhibitors were shown to induce p53 mutations in experimental systems. In the present article, we summarize what is known about MDM2 inhibitors as anti-cancer drugs with a focus on the acquisition of resistance to these compounds.

Overview

Integrity signals

Registry

Crossref · 10.1042/bst20140035

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 50 references

Cited by

See all 31

Metadata

Authors
Cinatl, J., Speidel, D., Hardcastle, I., & Michaelis, M.
Affiliations
  • Goethe University Frankfurt (DE)
  • The University of Sydney (AU)
  • Newcastle University (GB)
  • University of Kent (GB)
Corresponding author
Cinatl, Jindrich
Venue
Biochemical Society Transactions
Published
2014-08-01
Volume
42
Issue
4
Pages
752-757
ISSN
  • 0300-5127 (ISSN-L)
  • 1470-8752
OpenAlex
W2062745242
Cited by
30
References
50
Citations by year
2025: 5 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 2
FWCI
0.42
Type
journal article
Language
en
Open access
Locations
  • Biochemical Society Transactions (publishedVersion)
  • PubMed (publishedVersion)
  • Kent Academic Repository (University of Kent) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
MDM2 inhibitors, drug resistance, p53, p53-MDM2 interaction, TP53 mutation, small molecule inhibitors, cancer therapy, targeted therapy
MeSH terms
Animals, Antineoplastic Agents, Humans, Neoplasms, Signal Transduction, Tumor Suppressor Protein p53, Drug Resistance, Neoplasm, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resistance acquisition to MDM2 inhibitors. https://app.cochat.ai/papers/10.1042/bst20140035
The paper
Cinatl, J., Speidel, D., Hardcastle, I., & Michaelis, M. (2014). Resistance acquisition to MDM2 inhibitors. Biochemical Society Transactions. https://doi.org/10.1042/bst20140035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.